M Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)
Co-investorsARCH Venture PartnersNorthpond VenturesNovalis LifeSciences
Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health.
AI & Machine LearningBiotechDigital HealthFemTechHealthtech
Rene Bharti(Co-founder)Dr. Dan Nayot(Co-founder)
Co-investorsWhitecap Venture PartnersGaingelsSandpiper Ventures
Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.
BiotechDeep TechHealthtech
Co-investors+ND CapitalIllumina VenturesLongwall Venture Partners LLPOMX VenturesARCH Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.